JosephPhilipVacantiMD
Pediatric (General) Surgery • Boston, MAJohn Homans Professor of Surgery, Massachusetts General Hospital
Are you Dr. Vacanti?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 91 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Wrn 1157
Boston, MA 02114Phone+1 617-724-1725Fax+1 617-726-7593
Summary
- Dr. Joseph Vacanti, MD is a Pediatric Surgeon in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Massachusetts General Hospital and is a John Homans Professor of Surgery at Massachusetts General Hospital.
Education & Training
Massachusetts General HospitalResidency, Surgery, 1979 - 1980- Massachusetts General HospitalResidency, Surgery, 1974 - 1977
University of Nebraska College of MedicineClass of 1974
Certifications & Licensure
MA State Medical License 1974 - 2025
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2001
- Fellow (FACS) American College of Surgeons
- Fellow (FAAP) American Academy of Pediatrics
Publications & Presentations
PubMed
- Implantable 3D printed hydrogels with intrinsic channels for liver tissue engineering.Tyler J Lieberthal, Tatevik Sahakyants, Naomi R Szabo-Wexler, Matthew J Hancock, Andrew P Spann
Proceedings of the National Academy of Sciences of the United States of America. 2024-11-19 - Thirtieth Anniversary of Tissue Engineering: A Congratulations and a Few Thoughts.Joseph P Vacanti
Tissue Engineering. Part A. 2024-02-01 - 1 citationsRodent Model for Orthotopic Implantation of Engineered Liver Devices.Tatevik Sahakyants, Tyler J Lieberthal, Carly D Comer, Matthew J Hancock, Andrew P Spann
Tissue Engineering. Part C, Methods. 2023-01-01
Press Mentions
- InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord InjuryMarch 9th, 2023
- InVivo Therapeutics Announces Publication of 12- and 24-Month Data for INSPIRE 1.0 Study in Peer-Reviewed NeurosurgeryJune 8th, 2022
InVivo Therapeutics : Announces Participation at Upcoming H.C. Wainwright Annual Global Investment ConferenceSeptember 9th, 2021- Join now to see all
Grant Support
- Bioengineering Of Transplantable Humanized Lungs From IPS CellsNational Heart, Lung, And Blood Institute2011
- Tissue Engineering Of Blood Vessel SubstitutesNational Heart, Lung, And Blood Institute1999–2002
- Tissue Engineering Of Blood Vessel SubstitutesNational Heart, Lung, And Blood Institute1998
Professional Memberships
- Fellow
- Member
